| Catalog Number |
06656021190 |
| Medical Device Problem Code |
High Test Results (2457)
|
| Health Effect - Clinical Code |
No Clinical Signs, Symptoms or Conditions (4582)
|
| Date of Event |
06/20/2025
|
|
Type of Reportable Event
|
Malfunction
|
|
Event or Problem Description
|
|
We received an allegation of discrepant results for 1 patient sample tested for elecsys estradiol iii assay (estradiol iii) and elecsys fsh (fsh) on a cobas 6000 e601 module.The estradiol iii result from the e601 module was 769.20 pmol/l.The sample was repeated twice on the e601 module with results of 800.8 pmol/l and 804.6 pmol/l.The fsh result from the e601 module was 1.31 iu/l.The doctor questioned the estradiol result as it was not consistent with the patient¿s condition.The sample was repeated by a competitor method, and the estradiol result was < 55.1 pmol/l, and the fsh result was 1.85 miu/ml.This medwatch will cover estradiol iii.Refer to medwatch with a1 patient identifier pt- (b)(6) for information on the fsh results.
|
| |
|
Additional Manufacturer Narrative
|
|
The competitor method was beckman.The e601 module serial number was (b)(6).The sample was requested for investigation.
|
| |
|
Additional Manufacturer Narrative
|
|
Calibration and qc were acceptable.The sample was received for investigation.The investigation reproduced the customer's high estradiol result: 222 pg/ml (815.05 pmol/l).Upon further investigation of the patient sample, an interferent against the streptavidin component of the reagent was confirmed.This interference is covered in product labeling: "in rare cases, interference due to extremely high titers of antibodies to analyte-specific antibodies, streptavidin or ruthenium can occur.These effects are minimized by suitable test design.For diagnostic purposes, the results should always be assessed in conjunction with the patient¿s medical history, clinical examination and other findings." the investigation did not identify a product problem.
|
| |
|
Search Alerts/Recalls
|